Defining the regulatory logic of breast cancer using single-cell epigenetic and transcriptome profiling

Cell Genom. 2025 Feb 12;5(2):100765. doi: 10.1016/j.xgen.2025.100765. Epub 2025 Feb 5.

Abstract

Annotation of cis-regulatory elements that drive transcriptional dysregulation in cancer cells is critical to understanding tumor biology. Herein, we present matched chromatin accessibility (single-cell assay for transposase-accessible chromatin by sequencing [scATAC-seq]) and transcriptome (single-cell RNA sequencing [scRNA-seq]) profiles at single-cell resolution from human breast tumors and healthy mammary tissues processed immediately following surgical resection. We identify the most likely cell of origin for subtype-specific breast tumors and implement linear mixed-effects modeling to quantify associations between regulatory elements and gene expression in malignant versus normal cells. These data unveil cancer-specific regulatory elements and putative silencer-to-enhancer switching events in cells that lead to the upregulation of clinically relevant oncogenes. In addition, we generate matched scATAC-seq and scRNA-seq profiles for breast cancer cell lines, revealing a conserved oncogenic gene expression program between in vitro and in vivo cells. This work highlights the importance of non-coding regulatory mechanisms that underlie oncogenic processes and the ability of single-cell multi-omics to define the regulatory logic of cancer cells.

Keywords: breast cancer; chromatin accessibility; enhancer elements; gene regulation; scATAC-seq; scRNA-seq; single-cell genomics; single-cell multi-omics.

MeSH terms

  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / pathology
  • Cell Line, Tumor
  • Chromatin / genetics
  • Chromatin / metabolism
  • Epigenesis, Genetic* / genetics
  • Female
  • Gene Expression Profiling* / methods
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Sequence Analysis, RNA
  • Single-Cell Analysis* / methods
  • Transcriptome / genetics

Substances

  • Chromatin